Wird geladen...
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
Plecanatide is a recently developed guanylate cyclase‐C (GC‐C) agonist and the first uroguanylin analog designed to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS‐C). GC‐C receptors are found across the length of the intestines and are thought to play...
Gespeichert in:
Veröffentlicht in: | Pharmacol Res Perspect |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
John Wiley and Sons Inc.
2017
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5368960/ https://ncbi.nlm.nih.gov/pubmed/28357122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.295 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|